APA (7th ed.) Citation

TL, L., LAE, P., LA, N., RGC, F., ZDS, B., LP, S., . . . EM, D. (2026). Aryl-Cyclohexanone as a potential CB2 agonist: In vitro and in silico evidence in inflammatory modulation. Immunopharmacology and immunotoxicology, 48(3), 414. https://doi.org/10.1080/08923973.2026.2655385

Chicago Style (17th ed.) Citation

TL, Lubschinski, Pollo LAE, Nardino LA, Filho RGC, Buss ZDS, Sandjo LP, Biavatti MW, Federico LB, and Dalmarco EM. "Aryl-Cyclohexanone as a Potential CB2 Agonist: In Vitro and in Silico Evidence in Inflammatory Modulation." Immunopharmacology and Immunotoxicology 48, no. 3 (2026): 414. https://doi.org/10.1080/08923973.2026.2655385.

MLA (9th ed.) Citation

TL, Lubschinski, et al. "Aryl-Cyclohexanone as a Potential CB2 Agonist: In Vitro and in Silico Evidence in Inflammatory Modulation." Immunopharmacology and Immunotoxicology, vol. 48, no. 3, 2026, p. 414, https://doi.org/10.1080/08923973.2026.2655385.